SLC30A3 polymorphisms in humans can lead to ZnT-3 loss of function phenotypes, that were reported to increase seizure susceptibility as well as the risk of schizophrenia (McAllister and Dyck, 2017). Here, SLC30A3 is linked to schizophrenia.